Skip to main content
OpenTrials

Clinical trial condition

Recurrent Vulvovaginal Candidiasis

Explore clinical trials studying Recurrent Vulvovaginal Candidiasis. Study availability and eligibility vary by location and protocol.

10 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Recurrent Vulvovaginal Candidiasis trial results

Completed

A Study of Oral Oteseconazole (VT-1161) for the Treatment of Patients With Recurrent Vaginal Candidiasis (Yeast Infection)

NCT03561701

Conditions
Bacterial Infections and Mycoses, Candidiasis, Candidiasis, Vulvovaginal, +13 more
Locations
  • 31215 Phoenix, Arizona, United States
  • 31227 Little Rock, Arkansas, United States
  • 31217 Los Angeles, California, United States
  • 31240 Hartford, Connecticut, United States
View all 14 locations
View Trial Details
Completed

A Study of Oral Oteseconazole for the Treatment of Patients With Recurrent Vaginal Candidiasis (Yeast Infection)

NCT03562156

Conditions
Bacterial Infections and Mycoses, Candidiasis, Candidiasis, Vulvovaginal, +13 more
Locations
  • 31123 Birmingham, Alabama, United States
  • 31108 San Diego, California, United States
  • 31139 Lauderdale Lakes, Florida, United States
  • 31143 Sarasota, Florida, United States
View all 25 locations
View Trial Details
Completed

Study to Evaluate the Efficacy and Safety of Ibrexafungerp in Patients With Fungal Diseases That Are Refractory to or Intolerant of Standard Antifungal Treatment

NCT03059992

Conditions
Allergic Bronchopulmonary Aspergillosis, Aspergillosis, Aspergillosis, Allergic Bronchopulmonary, +44 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • UC Davis Medical Center Sacramento, California, United States
  • University of California San Francisco San Francisco, California, United States
  • Emory University Hospital Midtown Atlanta, Georgia, United States
View all 37 locations
View Trial Details
Completed

Phase 3 Study of Oral Ibrexafungerp (SCY-078) Vs. Placebo in Subjects With Recurrent Vulvovaginal Candidiasis (VVC)

NCT04029116

Conditions
Bacterial Infections and Mycoses, Candidiasis, Candidiasis, Vulvovaginal, +13 more
Locations
  • Precision Trials LLC Phoenix, Arizona, United States
  • Women's Healthcare Research Corp San Diego, California, United States
  • Altus Research - Hunt - PPDS Lake Worth, Florida, United States
  • New Age Medical Research Corporation Miami, Florida, United States
View all 25 locations
View Trial Details
Completed

Study of Oral Oteseconazole (VT-1161) for Acute Yeast Infections in Patients With Recurrent Yeast Infections

NCT03840616

Conditions
Bacterial Infections and Mycoses, Candidiasis, Candidiasis, Vulvovaginal, +13 more
Locations
  • 34 Tucson, Arizona, United States
  • 39 Encino, California, United States
  • 25 Los Angeles, California, United States
  • 22 Englewood, Colorado, United States
View all 33 locations
View Trial Details
Completed

A Study to Evaluate Oral VT-1161 in the Treatment of Patients With Recurrent Vaginal Candidiasis (Yeast Infection)

NCT02267382

Conditions
Bacterial Infections and Mycoses, Candidiasis, Candidiasis, Vulvovaginal, +13 more
Locations
  • University of Alabama Birmingham Birmingham, Alabama, United States
  • Precision Trials Phoenix, Arizona, United States
  • NEA Baptist Clinic Jonesboro, Arkansas, United States
  • Axis Clinical Trials Los Angeles, California, United States
View all 32 locations
View Trial Details
Active, Not Recruiting

Assessing the Safety, Immune Response, and Early Efficacy of a Candida Vaccine in Women With Recurrent Vulvovaginal Candidiasis: A Randomized Controlled Study

NCT06190509

Conditions
Bacterial Infections and Mycoses, Candidiasis, Candidiasis, Vulvovaginal, +13 more
Locations
  • Femicare Tienen, Belgium
  • Universitair Ziekenhuis Gent Ghent, Belgium
  • Aidport sp.z o.o. Skórzewo, Poznan, Poland
  • IN-VIVO Sp. z o.o. Bydgoszcz, Poland
View Trial Details

Related conditions